{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T19:46:20Z","timestamp":1793303180524,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T00:00:00Z","timestamp":1702512000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T00:00:00Z","timestamp":1702512000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Guangxi Zhuang Autonomous Region Health Commission","award":["Z20200134"],"award-info":[{"award-number":["Z20200134"]}],"id":[{"id":"https:\/\/ror.org\/01x9sys47","id-type":"ROR","asserted-by":"crossref"}]},{"name":"The Specific Research Project of Guangxi for Research Bases and Talents","award":["Guike-AD21220042"],"award-info":[{"award-number":["Guike-AD21220042"]}]},{"name":"The Major Project of Science and Technology of Guangxi Zhuang Autonomous Region","award":["Guike-AA22096018"],"award-info":[{"award-number":["Guike-AA22096018"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>A connection between lymphovascular invasion and axillary lymph node metastases in breast cancer has been observed, but the findings are inconsistent and primarily based on research in Western populations. We investigated the association between lymphovascular invasion and non-sentinel lymph node (non-SLN) metastasis in breast cancer patients with sentinel lymph node (SLN) metastasis in western China.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This study comprised 280 breast cancer patients who tested positive for SLN through biopsy and subsequently underwent axillary lymph node dissection (ALND) at The People\u2019s Hospital of Guangxi Zhuang Autonomous Region between March 2013 and July 2022. We used multivariate logistic regression analyses to assess the association between clinicopathological characteristics and non-SLN metastasis. Additionally, we conducted further stratified analysis. Results: Among the 280 patients with positive SLN, only 126 (45%) exhibited non-SLN metastasis. Multivariate logistic regression demonstrated that lymphovascular invasion was an independent risk factor for non-SLN in breast cancer patients with SLN metastasis (OR\u2009=\u20096.11; 95% CI, 3.62\u201310.32,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05). The stratified analysis yielded similar results.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In individuals with invasive breast cancer and 1\u20132 positive sentinel lymph nodes, lymphovascular invasion is the sole risk factor for non-SLN metastases. This finding aids surgeons and oncologists in devising a plan for local axillary treatment, preventing both over- and undertreatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12957-023-03273-6","type":"journal-article","created":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T05:06:11Z","timestamp":1702616771000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Lymphovascular invasion is a significant risk factor for non-sentinel nodal metastasis in breast cancer patients with sentinel lymph node (SLN)-positive breast cancer: a cross-sectional study"],"prefix":"10.1186","volume":"21","author":[{"given":"Chunyu","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongqing","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suosu","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingguang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanqing","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianrong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,14]]},"reference":[{"issue":"3","key":"3273_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"3273_CR2","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/tbj.13720","volume":"26","author":"JM Dixon","year":"2020","unstructured":"Dixon JM, Cartlidge CWJ. Twenty-five years of change in the management of the axilla in breast cancer. Breast J. 2020;26(1):22\u20136.","journal-title":"Breast J"},{"issue":"6","key":"3273_CR3","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1056\/NEJMoa012782","volume":"349","author":"U Veronesi","year":"2003","unstructured":"Veronesi U, et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med. 2003;349(6):546\u201353.","journal-title":"N Engl J Med"},{"issue":"10","key":"3273_CR4","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/S1470-2045(10)70207-2","volume":"11","author":"DN Krag","year":"2010","unstructured":"Krag DN, et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol. 2010;11(10):927\u201333.","journal-title":"Lancet Oncol"},{"issue":"6","key":"3273_CR5","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1001\/jama.2011.90","volume":"305","author":"AE Giuliano","year":"2011","unstructured":"Giuliano AE, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA. 2011;305(6):569\u201375.","journal-title":"JAMA"},{"issue":"7","key":"3273_CR6","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1245\/s10434-010-0945-z","volume":"17","author":"ME Straver","year":"2010","unstructured":"Straver ME, et al. Sentinel node identification rate and nodal involvement in the EORTC 10981\u201322023 AMAROS trial. Ann Surg Oncol. 2010;17(7):1854\u201361.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"3273_CR7","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s10549-020-05842-9","volume":"184","author":"W Gao","year":"2020","unstructured":"Gao W, et al. Axillary lymph node and non-sentinel lymph node metastasis among the ACOSOG Z0011 eligible breast cancer patients with invasive ductal, invasive lobular, or other histological special types: a multi-institutional retrospective analysis. Breast Cancer Res Treat. 2020;184(1):193\u2013202.","journal-title":"Breast Cancer Res Treat"},{"key":"3273_CR8","doi-asserted-by":"publisher","unstructured":"Bartels SAL, Donker M, Poncet C, et al. Radiotherapy or Surgery of the Axilla After a Positive Sentinel Node in Breast Cancer: 10-Year Results of the Randomized Controlled EORTC 10981-22023 AMAROS Trial. J Clin Oncol. 2023;41(12):2159-65. https:\/\/doi.org\/10.1200\/JCO.22.01565.","DOI":"10.1200\/JCO.22.01565"},{"issue":"13","key":"3273_CR9","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1200\/JCO.2013.54.1177","volume":"32","author":"GH Lyman","year":"2014","unstructured":"Lyman GH, et al. Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2014;32(13):1365\u201383.","journal-title":"J Clin Oncol"},{"issue":"1","key":"3273_CR10","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/BF02710021","volume":"7","author":"IP Callejo","year":"2005","unstructured":"Callejo IP, et al. Predictors of positive axillary lymph nodes in breast cancer patients with metastatic sentinel lymph node. Clin Transl Oncol. 2005;7(1):18\u201322.","journal-title":"Clin Transl Oncol"},{"issue":"3","key":"3273_CR11","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1002\/cncr.20809","volume":"103","author":"G Viale","year":"2005","unstructured":"Viale G, et al. Predicting the status of axillary sentinel lymph nodes in 4351 patients with invasive breast carcinoma treated in a single institution. Cancer. 2005;103(3):492\u2013500.","journal-title":"Cancer"},{"issue":"20","key":"3273_CR12","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.21037\/atm-21-5169","volume":"9","author":"J Zhang","year":"2021","unstructured":"Zhang J, et al. Analysis of sentinel lymph node biopsy and non-sentinel lymph node metastasis in invasive ductal and invasive lobular breast cancer: a nationwide cross-sectional study (CSBrS-001). Ann Transl Med. 2021;9(20):1588.","journal-title":"Ann Transl Med"},{"issue":"5\u20136","key":"3273_CR13","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s10585-018-9902-1","volume":"35","author":"SD Nathanson","year":"2018","unstructured":"Nathanson SD, et al. Breast cancer metastasis through the lympho-vascular system. Clin Exp Metastasis. 2018;35(5\u20136):443\u201354.","journal-title":"Clin Exp Metastasis"},{"issue":"2","key":"3273_CR14","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.cell.2011.09.024","volume":"147","author":"S Valastyan","year":"2011","unstructured":"Valastyan S, Weinberg RA. Tumor metastasis: molecular insights and evolving paradigms. Cell. 2011;147(2):275\u201392.","journal-title":"Cell"},{"issue":"2","key":"3273_CR15","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3322\/caac.21388","volume":"67","author":"MB Amin","year":"2017","unstructured":"Amin MB, et al. The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging. CA Cancer J Clin. 2017;67(2):93\u20139.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"3273_CR16","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s10549-017-4270-0","volume":"164","author":"AA Muftah","year":"2017","unstructured":"Muftah AA, et al. Ki67 expression in invasive breast cancer: the use of tissue microarrays compared with whole tissue sections. Breast Cancer Res Treat. 2017;164(2):341\u20138.","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"3273_CR17","first-page":"78","volume":"45","author":"B Sidhu","year":"2018","unstructured":"Sidhu B, et al. American Joint Committee on Cancer (AJCC) Cancer Staging Eighth Edition: Prognostic vs Anatomic Path Stage Group for Breast Cancer. J Registry Manag. 2018;45(2):78\u20139.","journal-title":"J Registry Manag"},{"issue":"45","key":"3273_CR18","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000004201","volume":"95","author":"N-S Huang","year":"2016","unstructured":"Huang N-S, et al. Surgical management of breast cancer in China: A 15-year single-center retrospective study of 18,502 patients. Medicine. 2016;95(45): e4201.","journal-title":"Medicine"},{"key":"3273_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.753209","volume":"11","author":"L Gu","year":"2021","unstructured":"Gu L, et al. Comparing hypofractionated with conventional fractionated radiotherapy after breast-conserving surgery for early breast cancer: a meta-analysis of randomized controlled trials. Front Oncol. 2021;11: 753209.","journal-title":"Front Oncol"},{"issue":"3","key":"3273_CR20","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s40257-016-0186-4","volume":"17","author":"M Singh","year":"2016","unstructured":"Singh M, et al. Radiodermatitis: a review of our current understanding. Am J Clin Dermatol. 2016;17(3):277\u201392.","journal-title":"Am J Clin Dermatol"},{"issue":"2","key":"3273_CR21","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1111\/j.1349-7006.2011.02148.x","volume":"103","author":"K Chen","year":"2012","unstructured":"Chen K, et al. Validation and comparison of models to predict non-sentinel lymph node metastasis in breast cancer patients. Cancer Sci. 2012;103(2):274\u201381.","journal-title":"Cancer Sci"},{"issue":"3","key":"3273_CR22","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1002\/bjs.5943","volume":"95","author":"A Pal","year":"2008","unstructured":"Pal A, et al. A model for predicting non-sentinel lymph node metastatic disease when the sentinel lymph node is positive. Br J Surg. 2008;95(3):302\u20139.","journal-title":"Br J Surg"},{"issue":"6","key":"3273_CR23","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.amjsurg.2006.08.063","volume":"192","author":"AB Chagpar","year":"2006","unstructured":"Chagpar AB, et al. Prediction of sentinel lymph node-only disease in women with invasive breast cancer. Am J Surg. 2006;192(6):882\u20137.","journal-title":"Am J Surg"},{"issue":"1","key":"3273_CR24","doi-asserted-by":"publisher","first-page":"19972","DOI":"10.1038\/s41598-021-99522-3","volume":"11","author":"L Meng","year":"2021","unstructured":"Meng L, et al. Development of a prediction model based on LASSO regression to evaluate the risk of non-sentinel lymph node metastasis in Chinese breast cancer patients with 1\u20132 positive sentinel lymph nodes. Sci Rep. 2021;11(1):19972.","journal-title":"Sci Rep"},{"key":"3273_CR25","first-page":"31","volume":"6","author":"Y Andersson","year":"2012","unstructured":"Andersson Y, et al. Prediction of non-sentinel lymph node status in breast cancer patients with sentinel lymph node metastases: evaluation of the tenon score. Breast Cancer. 2012;6:31\u20138.","journal-title":"Breast Cancer"},{"issue":"2","key":"3273_CR26","doi-asserted-by":"publisher","first-page":"e210","DOI":"10.3747\/co.26.4295","volume":"26","author":"XY Wang","year":"2019","unstructured":"Wang XY, et al. Risk factors and a predictive nomogram for non-sentinel lymph node metastases in Chinese breast cancer patients with one or two sentinel lymph node macrometastases and mastectomy. Curr Oncol. 2019;26(2):e210\u20135.","journal-title":"Curr Oncol."},{"issue":"3","key":"3273_CR27","doi-asserted-by":"publisher","first-page":"282","DOI":"10.20892\/j.issn.2095-3941.2018.0023","volume":"15","author":"A Maimaitiaili","year":"2018","unstructured":"Maimaitiaili A, et al. Analysis of factors related to non-sentinel lymph node metastasis in 296 sentinel lymph node-positive Chinese breast cancer patients. Cancer Biol Med. 2018;15(3):282\u20139.","journal-title":"Cancer Biol Med"},{"key":"3273_CR28","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jss.2021.09.039","volume":"271","author":"X Wang","year":"2022","unstructured":"Wang X, et al. Sentinel lymph node positive rate predicts non-sentinel lymph node metastasis in breast cancer. J Surg Res. 2022;271:59\u201366.","journal-title":"J Surg Res"},{"issue":"7","key":"3273_CR29","doi-asserted-by":"publisher","first-page":"3738","DOI":"10.1245\/s10434-020-09288-7","volume":"28","author":"MS Kedrzycki","year":"2021","unstructured":"Kedrzycki MS, et al. Meta-analysis comparing fluorescence imaging with radioisotope and blue dye-guided sentinel node identification for breast cancer surgery. Ann Surg Oncol. 2021;28(7):3738\u201348.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"3273_CR30","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1186\/s12885-019-5823-x","volume":"19","author":"S Majid","year":"2019","unstructured":"Majid S, Ryden L, Manjer J. Determinants for non-sentinel node metastases in primary invasive breast cancer: a population-based cohort study of 602 consecutive patients with sentinel node metastases. BMC Cancer. 2019;19(1):626.","journal-title":"BMC Cancer"},{"issue":"4","key":"3273_CR31","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.asjsur.2019.07.019","volume":"43","author":"A Lale","year":"2020","unstructured":"Lale A, et al. Predictors of non-sentinel lymph node metastasis in clinical early stage (cT1-2N0) breast cancer patients with 1\u20132 metastatic sentinel lymph nodes. Asian J Surg. 2020;43(4):538\u201349.","journal-title":"Asian J Surg"},{"issue":"11","key":"3273_CR32","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1002\/bjs.10583","volume":"104","author":"L Dihge","year":"2017","unstructured":"Dihge L, Bendahl PO, Ryd\u00e9n L. Nomograms for preoperative prediction of axillary nodal status in breast cancer. Br J Surg. 2017;104(11):1494\u2013505.","journal-title":"Br J Surg"},{"issue":"2","key":"3273_CR33","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s10549-019-05482-8","volume":"179","author":"D Mitra","year":"2020","unstructured":"Mitra D, et al. Phosphorylation of EphA2 receptor and vasculogenic mimicry is an indicator of poor prognosis in invasive carcinoma of the breast. Breast Cancer Res Treat. 2020;179(2):359\u201370.","journal-title":"Breast Cancer Res Treat"},{"issue":"7","key":"3273_CR34","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.ejso.2016.02.259","volume":"42","author":"A Nottegar","year":"2016","unstructured":"Nottegar A, et al. Extra-nodal extension of sentinel lymph node metastasis is a marker of poor prognosis in breast cancer patients: A systematic review and an exploratory meta-analysis. Eur J Surg Oncol. 2016;42(7):919\u201325.","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"3273_CR35","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1186\/s12885-017-3338-x","volume":"17","author":"S Zhang","year":"2017","unstructured":"Zhang S, et al. High lymphatic vessel density and presence of lymphovascular invasion both predict poor prognosis in breast cancer. BMC Cancer. 2017;17(1):335.","journal-title":"BMC Cancer"},{"issue":"9","key":"3273_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0204364","volume":"13","author":"J Li","year":"2018","unstructured":"Li J, et al. Sentinel lymph node biopsy mapped with methylene blue dye alone in patients with breast cancer: A systematic review and meta-analysis. PLoS ONE. 2018;13(9): e0204364.","journal-title":"PLoS ONE"},{"issue":"1","key":"3273_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000340016","volume":"84","author":"SK Lee","year":"2013","unstructured":"Lee SK, et al. The clinical meaning of intramammary lymph nodes. Oncology. 2013;84(1):1\u20135.","journal-title":"Oncology"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-023-03273-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-023-03273-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-023-03273-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T16:21:46Z","timestamp":1714494106000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-023-03273-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,14]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3273"],"URL":"https:\/\/doi.org\/10.1186\/s12957-023-03273-6","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,14]]},"assertion":[{"value":"6 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study protocol was reviewed and approved by the ethics committee of the Ethics Committee of the Guangxi Zhuang Autonomous Region People\u2019s Hospital (Ethics-KY-QT-202205). Written informed consent was waived by The Ethics Committee of the Guangxi Zhuang Autonomous Region People\u2019s Hospital due to the retrospective observational nature of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"386"}}